Sublicense Revenue Sharing. Akcea will pay Isis 50% of the Sublicense Revenue; provided, however, for a Sublicensee royalty under a co-promote or co-detail, Akcea may deduct from Sublicense Revenue the Sales & Marketing Expenses Akcea (i) actually incurs, (ii) is contractually obligated to contribute under the applicable co-promote or co-detail agreement and (iii) has not otherwise been reimbursed to Akcea by such Sublicensee under the applicable co-promote or co-detail agreement. If Akcea enters into a series of agreements with a Third Party or any of such Third Party’s Affiliates pursuant to which Akcea grants such Third Party or its Affiliates a Sublicense under at least one of such agreements, then, such agreements will be aggregated together and treated as a single Sublicense for purposes of calculating Sublicense Revenue under this Agreement;
Sublicense Revenue Sharing. In addition to the milestones and royalty payments set forth in Sections 8.2 and 8.4, Eiger shall pay to BMS the following percentage of all Sublicense Revenues Eiger receives in connection with any Sublicense or any assignment of rights to the BMS Patents, the Licensed Compounds and/or Licensed Products, depending on the stage of Development of the most advanced Licensed Compound or Licensed Product that is subject to the applicable Sublicense or such assignment. Eiger shall pay to BMS its share of Sublicense Revenues within [ * ] after receipt of payment by Eiger from the Sublicensee. DEVELOPMENT STAGE OF LICENSED COMPOUND OR LICENSED PRODUCT AS OF THE DATE OF THE SUBLICENSE [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.
Sublicense Revenue Sharing. Subject to Section 4.12, MDCO shall pay to Eagle [*] of all Sublicensing Revenue received by MDCO or its Affiliates; provided, however, that, subject to Section 2.5, if any Third Party (or Eagle or its Affiliates if Section 8.1.3 applies) launches or otherwise Exploits any Generic Competing Product on or before [*] (even if the launch of such Generic Competing Product occurs on or before [*], but the thirty (30) consecutive day sale period described in the definition of Generic Competing Product has not yet been achieved as of [*] but is achieved thereafter within thirty (30) days after such launch date), then from and after the launch date of such Generic Competing Product, the portion of Sublicensing Revenue payable to Eagle with respect to Products pursuant to this Section 4.4 shall be reduced to [*] of such Sublicensing Revenue. Such portion of Sublicensing Revenue shall be payable quarterly, within forty-five (45) days after the end of the calendar quarter in which the applicable Sublicensee pays to MDCO or its Affiliate the underlying Sublicensing Revenue.
Sublicense Revenue Sharing. In addition to the milestones and royalty payments set forth above, Licensee shall pay to Licensor a share of all Sublicense Revenues as set forth in the table below based on the stage of Development of the applicable Product when the sublicense agreement is executed. Licensee shall promptly notify Licensor of the receipt of any Sublicense Revenue and shall pay to Licensor its share of Sublicense Revenues within [***] after receipt of Sublicense Revenue by Licensee (or its Affiliates) from the sublicensee. The time when the sublicense agreement is executed Percentage of Sublicense Revenue Payable to Licensor
Sublicense Revenue Sharing. In addition to the milestones and royalty payments set forth in Sections 8.2 and 8.4, Company shall pay to BMS the following percentage of all Sublicense Revenues Company receives in connection with any Sublicense or any assignment of rights to the BMS Patents, the Licensed Compounds and/or Licensed Products, depending on the stage of Development of the most advanced Licensed Compound or Licensed Product that is subject to the applicable Sublicense or such assignment: Certain information marked as [***] has been excluded from this exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed. DEVELOPMENT STAGE OF LICENSED COMPOUND OR LICENSED PRODUCT AS OF THE DATE OF THE SUBLICENSE [***] [***] [***] PERCENT OF SUBLICENSE REVENUES PAYABLE TO BMS [ ***]% [ ***]% [ ***]% Certain information marked as [***] has been excluded from this exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed. DEVELOPMENT STAGE OF LICENSED COMPOUND OR LICENSED PRODUCT AS OF THE DATE OF THE ASSIGNMENT [***] [***] PERCENT OF SUBLICENSE REVENUES PAYABLE TO BMS [ ***]% [ ***]% Notwithstanding the foregoing, in the event Sublicense Revenue received by Company from a Sublicensee is for the same milestone event or royalty tier that Company pays BMS under this Agreement, the percent stated in the tables above shall apply only to Sublicense Revenue that is [***] the payment Company pays to BMS for the same milestone event or royalty tier under this Agreement ([***]). [***] For clarity, the percent stated in the above tables shall apply to any particular Sublicense Revenue that is not included in the Agreement (e.g., the upfront payment from the Sublicensee or a milestone payment for a milestone event not included in the Agreement).
Sublicense Revenue Sharing. In addition to the milestones and royalty payments set forth in Section 8.2, Company shall pay to BMS the following percentage of all Sublicense Revenues Company receives in connection with any Sublicense or any assignment of rights to the BMS Patents, BMS Know-How, the Licensed Compounds and/or Licensed Products, depending on the stage of Development of the most advanced Licensed Compound or Licensed Product that is subject to the applicable Sublicense or such assignment: Development stage of the most advanced Licensed Compound or Licensed Product as of the date of the Sublicense or assignment: Prior to delivery of top line data from the first Phase III Trial Prior to the first filing for an Approval Thereafter Percent of Sublicense Revenues payable to BMS [* * *] % [* * *] % [* * *] % For clarity the percent stated above shall apply (i) to any particular Sublicense Revenue that is not included in the Agreement (e.g., the upfront payment from the Sublicensee or a milestone payment for a milestone event not included in the Agreement), and (ii) to the difference between (x) the Sublicense Revenue payment received by Company from a Sublicensee and (y) the payment Company pays to BMS for a particular payment under the Agreement (e.g., the difference between the milestone payment Company receives from a Sublicensee and the milestone payment Company pays to BMS for the same milestone event or the difference between the royalty rates).
Sublicense Revenue Sharing. For each Sublicense granted by ASOthera, ASOthera will pay to University [*] of all Sublicense Revenue. For the avoidance of doubt, Net Sales of any Licensed Product by any sublicensee or sublicensee’s Affiliate are subject to ASOthera’s royalty obligation to University.
Sublicense Revenue Sharing. For each Sublicense granted by ASOthera, ASOthera will pay to CSHL [*] of all Sublicense Revenue. For the avoidance of doubt, Net Sales of any Licensed Product by any sublicensee or sublicensee’s Affiliate are subject to ASOthera’s royalty obligation to CSHL. The percentage of Sublicense Revenue payable to CSHL will be reduced to [*].
Sublicense Revenue Sharing. In consideration of Mosaic’s contributions to the Research and the licenses granted to Catalyst hereunder, Catalyst shall pay Mosaic a share of Sublicense Income of [***] of Catalyst’s Sublicense Income, paid in accordance with Article 11 below.
Sublicense Revenue Sharing. Isis’ obligations to pay CSHL Sublicense Revenue sharing payments under Section 4.1.6 of the Collaboration Agreement as a result of the [***] will be to pay CSHL [***]% of the [***] ([***]) and the [***] for achievement of [***] ([***]) received from [***]. Payment of [***]% of the [***] will be due to CSHL within [***] days of the end of the calendar quarter in which [***], and [***]% of each [***] for achievement of [***] will be due to CSHL within [***] days of the end of the calendar quarter in which the [***] was achieved. The [***] and [***] for achievement of [***] pursuant to the terms of the [***] in effect as of the date hereof, and the corresponding [***]% payments from Isis to CSHL, are set forth in the following table: Payment Event Pursuant to [***] Payment to Isis from [***] Corresponding [***]% payment from Isis to CSHL [***] $[***] $[***] [***] $[***] $[***] [***] $[***] $[***] [***] $[***] $[***]
